Skip to content

Azithromycin versus Erythromycin as a part of antibiotic prophylaxis in patients of PPROM and their relation with latency period and intrauterine infection

Single dose intravenous azithromycin versus multiple dose oral erythromycin as a part of antibiotic prophylaxis in management of PPROM and their relation with latency period and chorioamnionitis - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070762
Enrollment
200
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O429- Premature rupture of membranes, unspecified as to length of time between rupture and onset of labor

Interventions

Intervention1: Intravenous Azithromycin: Intravenous Azithromycin 1 gram stat Control Intervention1: Oral Erythromycin: Oral Erythromycin 250 mg QID for 7 days

Sponsors

Dept of Obstetrics and Gynaecology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with rupture of membranes from 24 weeks to 33 weeks + 6 days gestation

Exclusion criteria

Exclusion criteria: 1. Patients with established clinical chorioamnionitis on presentation 2. Conditions requiring ‘intentional delivery’ in PPROM 3. IUD or any lethal fetal congenital anomaly 4. Cord accidents 5. Multiple gestation 6. Patients who have received other antibiotics before presentation 7. Patients in active labour 8. Patients with cervical cerclage in situ

Design outcomes

Primary

MeasureTime frame
1.To compare the efficacy of a single dose of 1 g intravenous azithromycin to the 7-day course of 250 mg per oral erythromycin QID as a part of antibiotic prophylaxis in patients of PPROM (both regimen including a 2-day course of intravenous ampicillin followed by a 5-day course of per oral amoxicillin) with respect to the following outcomes: a.Duration of latency period b.Incidence of chorioamnionitis Timepoint: followup of 6 weeks post partum

Secondary

MeasureTime frame
2. To compare both regimens in terms of the following outcome parameters: a. Rates of Caesarean section b. Incidence of meconium-stained amniotic fluid (MSAF) c. Incidence of neonatal sepsis d. Incidence of postpartum endometritis Timepoint: followup of 6 weeks postpartum

Countries

India

Contacts

Public ContactProf Seema Hakim

Jawaharlal Nehru Medical College Hospital

drseemahakim@rediffmail.com9410643435

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026